Table 3.

PROMs of different categories reviewed in this article.

Approvals (n)	Generic QoL measures (n)	Other generic measures for symptom, function or safety (n)	Indication specific measures (n)
Solid tumours (33)	EORTC QLQ-C30 (20)/EQ-5D (20)/FACT-G (2)/PedsQL (2)/PGIC (1)	Bowel diaries (1)/BPI-SF (4)/FACIT-F (1)/HRU (1)/PGIC (Symptoms) (1)/WPAI-GH (1)	EORTC QLQ-BIL21 (1)/EORTC QLQ-BR23 (2)/EORTC QLQ-CX24 (1)/EORTC QLQ-G.I.NET21 (1)/EORTC QLQ-LC13 (5)/EORTC QLQ-PR25 (2)/FACT-B (1)/FACT-M (2)/FACT-P (3)/NFBSI-16 (1)/SMQ (1)
Haematological malignancies (12)	EORTC QLQ-C30 (4)/EQ-5D (7)/FACT-G (1)/PGIC (1)	NEI-VFQ-25 (1)/FACIT-F (1)/OSDI (1)/TINAS (1)/PRO-CTCAE (2)/Skindex-29 (1)	EORTC QLQ-MY20 (2)/FACT-Lym (2)/FACT-MM (1)/MFSAF (1)/MDASI-CML (1)/MPN-SAF (1)/WPAI-CML (1)

Abbreviations: BPI-SF, (modified) Brief Pain Inventory-Short Form; EQ-5D, EuroQol Five Dimensions Questionnaire; EORTC QLQ, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire; EORTC QLQ-BIL21, EORTC QLQ- Cholangiocarcinoma and Gallbladder Cancer; EORTC QLQ-BR23, EORTC QLQ-Breast Cancer; EORTC QLQ-CX24, EORTC QLQ-Cervical Cancer; EORTC QLQ-C30, EORTC QLQ-core questionnaire; EORTC QLQ-G.I.NET21, EORTC QLQ-Gastrointestinal neuroendocrine tumours; EORTC QLQ-LC13, EORTC QLQ-Lung Cancer; EORTC QLQ-MY20, EORTC QLQ-Multiple Myeloma; EORTC QLQ-PR25, EORTC QLQ-Prostate Cancer; FACIT-F, Functional Assessment of Chronic Illness Therapy–Fatigue; FACT, the Functional Assessment of Cancer Therapy; FACT-B, FACT-Breast; FACT-G, FACT-General; FACT-Lym, FACT-Lymphoma; FACT-M, FACT-Melanoma; FACT-MM, FACT-Multiple Myeloma; FACT-P, FACT-Prostate; HRU, Health Resource Utilization; MDASI-CML, MD Anderson Symptom Inventory-Chronic Myeloid Leukemia; MFSAF, Myelofibrosis Symptom Assessment Form; MPN-SAF, Myeloproliferative Neoplasm Symptom Assessment Form; NEI-VFQ-25, National Eye Institute Visual Function Questionnaire; NFBSI-16, National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index; OSDI, Ocular Surface Disease Index; PedsQL, Paediatric Quality of Life Inventory; PGIC, Patients' Global Impression of Change; PRO-CTCAE, Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events; SMQ, Symptom Measurement Questionnaire; TINAS, Therapy-Induced Neuropathy Assessment Scale; WPAI, Work Productivity and Activity Impairment questionnaire; WPAI-CML, WPAI-Chronic Myeloid Leukemia; WPAI-GH, WPAI-General Health.